Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

Tao YL, Wu DH, Zhou Q, Yang KY, Jin F, Zhu XD, Shi M, Hu GQ, Sun Y, Wu HF, Wu H, Lin Q, Wang H, Tian Y, Zhang N, Wang XC, Shen LF, Liu ZZ, Huang J, Luo XL, Li L, Zang J, Mei Q, Zheng BM, Yue D, Xu J, Wu SG, Chen L, Li WF, Zhou GQ, Sun R, Guo R, Zhang Y, Xu C, Lv JW, Guo Y, Feng HX, Tang LL, Xie FY, Liu X, Sun Y, Ma J, Mao YP, Chen YP

Open source

DOI
10.1038/s43018-026-01193-4
Published
2026 Jul
Container
Nature cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s43018-026-01193-4,
  title = {Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.},
  author = {Tao YL and Wu DH and Zhou Q and Yang KY and Jin F and Zhu XD and Shi M and Hu GQ and Sun Y and Wu HF and Wu H and Lin Q and Wang H and Tian Y and Zhang N and Wang XC and Shen LF and Liu ZZ and Huang J and Luo XL and Li L and Zang J and Mei Q and Zheng BM and Yue D and Xu J and Wu SG and Chen L and Li WF and Zhou GQ and Sun R and Guo R and Zhang Y and Xu C and Lv JW and Guo Y and Feng HX and Tang LL and Xie FY and Liu X and Sun Y and Ma J and Mao YP and Chen YP},
  year = {2026},
  journal = {Nature cancer},
  doi = {10.1038/s43018-026-01193-4},
  url = {https://doi.org/10.1038/s43018-026-01193-4}
}

RIS

TY  - JOUR
TI  - Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.
AU  - Tao YL
AU  - Wu DH
AU  - Zhou Q
AU  - Yang KY
AU  - Jin F
AU  - Zhu XD
AU  - Shi M
AU  - Hu GQ
AU  - Sun Y
AU  - Wu HF
AU  - Wu H
AU  - Lin Q
AU  - Wang H
AU  - Tian Y
AU  - Zhang N
AU  - Wang XC
AU  - Shen LF
AU  - Liu ZZ
AU  - Huang J
AU  - Luo XL
AU  - Li L
AU  - Zang J
AU  - Mei Q
AU  - Zheng BM
AU  - Yue D
AU  - Xu J
AU  - Wu SG
AU  - Chen L
AU  - Li WF
AU  - Zhou GQ
AU  - Sun R
AU  - Guo R
AU  - Zhang Y
AU  - Xu C
AU  - Lv JW
AU  - Guo Y
AU  - Feng HX
AU  - Tang LL
AU  - Xie FY
AU  - Liu X
AU  - Sun Y
AU  - Ma J
AU  - Mao YP
AU  - Chen YP
PY  - 2026
JO  - Nature cancer
DO  - 10.1038/s43018-026-01193-4
UR  - https://doi.org/10.1038/s43018-026-01193-4
ER  - 

APA

YL, T., DH, W., Q, Z., KY, Y., F, J., XD, Z., M, S., GQ, H., Y, S., HF, W., H, W., Q, L., H, W., Y, T., N, Z., XC, W., LF, S., ZZ, L., J, H., XL, L., L, L., J, Z., Q, M., BM, Z., D, Y., J, X., SG, W., L, C., WF, L., GQ, Z., R, S., R, G., Y, Z., C, X., JW, L., Y, G., HX, F., LL, T., FY, X., X, L., Y, S., J, M., YP, M., & YP, C. (2026). Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.. Nature cancer. https://doi.org/10.1038/s43018-026-01193-4

Source records